GGrantIndex
Sort

51,570 grants matching autoimmune disease

Aquaporin-4 in NMO Optic Neuritis: Pathogenesis and New Therapies

$391,637
Alan S Verkman · University Of California, San Francisco · R01 · FY2021 · EY

Multiplex in situ gene expression and phenotypical profiling of inflamed tissues

$391,598
Zoltan Laszik · University Of California, San Francisco · U24 · FY2017 · AI

Multiplex in situ gene expression and phenotypical profiling of inflamed tissues

$391,595
Zoltan Laszik · University Of California, San Francisco · U24 · FY2018 · AI

Deciphering the architecture of TLR signaling complexes

$391,572
Vladimir Y. Toshchakov · University Of Maryland Baltimore · R01 · FY2017 · AI

The 11S-associated immunoproteasome in mitochondrial function and metabolic disorders

$391,568
Do-Hyung Kim · University Of Minnesota · R01 · FY2024 · DK

Peripheral CD8+ T Cell Tolerance

$391,542
Linda A Sherman · Scripps Research Institute, The · R01 · FY2007 · DK

Co-evolutionary Genetics of Host-Parasite Interactions

$391,525
Noah K Whiteman · University Of California Berkeley · R35 · FY2020 · GM

Genetic Epidemiology of HAD Susceptibility Genes

$391,511
Sunil K Ahuja · University Of Texas Hlth Science Center · R01 · FY2007 · MH

PATHOGENESIS OF PRISTANE-INDUCED LUPUS

$391,507
Westley H Reeves · University Of Florida · R01 · FY2019 · AR

PATHOGENESIS OF PRISTANE-INDUCED LUPUS

$391,507
Westley H Reeves · University Of Florida · R01 · FY2020 · AR

The Role of Interleukin 23 in Lupus

$391,500
Vasileios Christos Kyttaris · Beth Israel Deaconess Medical Center · R01 · FY2016 · AR

Gene transcription in SLE

$391,500
George C Tsokos · Beth Israel Deaconess Medical Center · R37 · FY2013 · AI

Immunobiology of EAU Recovery Through the Melanocortin-Adenosinergic Pathway

$391,500
Darren James Lee · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · EY

The Role of Interleukin 23 in Lupus

$391,500
Vasileios Christos Kyttaris · Beth Israel Deaconess Medical Center · R01 · FY2015 · AR

The role of interleukin 23 in lupus

$391,500
Vasileios Christos Kyttaris · Beth Israel Deaconess Medical Center · R01 · FY2012 · AR

The role of Rap1 and its novel associated molecules in T cell responses

$391,500
Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R56 · FY2011 · AI

Molecular mechanism by which Tim-3 induces T cell dysfunction and inhibits anti-t

$391,493
Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2019 · AI

Ancillary T Cell Based Studies in SPIROMICS

$391,478
Farrah Kheradmand · Baylor College Of Medicine · R01 · FY2015 · HL

Phase 2 Study of Rasagiline for Treatment of Amyotrophic Lateral Sclerosis

$391,431
Richard J. Barohn · University Of Kansas Medical Center · R01 · FY2015 · FD

Development of Highly Multiplex Antigen Specificity Assays

$391,426
Harry Benjamin Larman · Johns Hopkins University · U24 · FY2017 · AI

Ad5 Fiber Entry and Trafficking in Lacrimal Acini

$391,375
Sarah F Hamm-Alvarez · University Of Southern California · R01 · FY2006 · EY

Mechanisms of Immunosuppressive Actions of Glucocorticoids

$391,369
Inez Rogatsky · Hospital For Special Surgery · R01 · FY2007 · AI

Psoriatic Regulatory T cell Dysfunction

$391,363
Kevin D Cooper · Case Western Reserve University · R01 · FY2014 · AR

The chromatin remodeler Mi2 in T cell development

$391,362
Katia Georgopoulos · Massachusetts General Hospital · R01 · FY2007 · AI

Monoclonal antibodies to inhibit Aspergillus germination

$391,357
Marta L. Feldmesser · Albert Einstein College Of Medicine · R01 · FY2010 · AI